Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lobectomy vs Total Thyroidectomy With Ipsilateral Lateral Neck Dissection for N1b Intermediate-Risk Papillary Thyroid Carcinoma.
Saito Y, Matsuzu K, Abdelhamid Ahmed AH, Inoue K, Shibuya H, Matsui A, Kuga Y, Ono R, Yoshioka K, Masaki C, Akaishi J, Hames KY, Okamura R, Tomoda C, Suzuki A, Kitagawa W, Nagahama M, Sugino K, Takami H, Randolph GW, Ito K. Saito Y, et al. Among authors: okamura r. JAMA Otolaryngol Head Neck Surg. 2024 Nov 27. doi: 10.1001/jamaoto.2024.3860. Online ahead of print. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 39602155
High Ki-67 Expression Predicting a Risk Factor for the Progression of Disease within 24 Months and Microenvironment in Follicular Lymphoma.
Narita H, Kuroiwa K, Kawaguchi Y, Murai S, Sasaki Y, Homma M, Kawamata N, Hayashi H, Nagao K, Okamura R, Uesugi Y, Sasaki Y, Shimada S, Watanuki M, Arai N, Yanagisawa K, Shiozawa E, Yamochi T, Hattori N. Narita H, et al. Among authors: okamura r. Int J Mol Sci. 2024 Oct 15;25(20):11057. doi: 10.3390/ijms252011057. Int J Mol Sci. 2024. PMID: 39456838 Free PMC article.
Robot-assisted extended rectal anterior resection for peritoneal dissemination of hepatocellular carcinoma invading rectum after atezolizumab plus bevacizumab combined therapy.
Hirata W, Itatani Y, Hida K, Okamura R, Hoshino N, Maekawa H, Nishigori T, Hisamori S, Tsunoda S, Obama K. Hirata W, et al. Among authors: okamura r. Int Cancer Conf J. 2024 Jun 5;13(4):336-341. doi: 10.1007/s13691-024-00688-0. eCollection 2024 Oct. Int Cancer Conf J. 2024. PMID: 39398904
242 results